Click here to go to the previous page
Utilization of Quantitative Imaging (QI) for Tumor Response Assessment
Program Code:
PAN09
Date:
Monday, November 2, 2009
SPEAKER(S):
Click the plus sign to see more detailed information
about each speaker.
Jeff Michalski, Vice Chairman and Director for Clinical Programs,
Washington University Medical Center
Dr. Michalski is the Vice Chair of the RTOG and a recognized expert in prostate cancer and clnical trials utilizing advanced technology. He has published numerous articles on prostate cancer, 3D conformal radiation therapy, IMRT and SBRT.
|
James Balter, Professor, University of Michigan
I am a program director and subject matter expert in the Radiation Research Program at the NCI with responsibility for the physics of the radiotherapy process including the application of imaging for planning and response assessment.
|
Dr. Buatti received undergraduates degrees in Biology and Theology from Georgetown University in Washington D.C. He completed medical school at Georgetown as well as a residency in Internal Medicine. He did a second residency in Radiation Oncology at the University of Arizona where he did laboratory work on oncogene expression following polyamine modulation. He took a first faculty position at the University of Florida where he rose to the rank of Associate Professor with tenure and received an endowed chair in Neurosurgery. His research with collaborators in Neurosurgery dealt with stereotactic guidance and optic guidance for radiosurgery applications. He has joint patents on infrared optic guidance of radiotherapy and radiosurgery. He left the University in 1999 to become the first Professor and Head of the newly created Department of Radiation Oncology at the University of Iowa and lead efforts for construction of the new Center of Excellence in Image-Guided Radiation Therapy. The current department has unparalleled imaging for simulation with a respiratory gated 40 slice PET/CT as well as 3T MRI. Integration of multimodality imaging to include functional and molecular imaging with FDG, FLT, C11-acetate and MRSI are all under investigation. Imaging of tumor response and motion during image guided radiation therapy are all critical interests for improving therapy. Close interdisciplinary interactions with biologists, imaging scientists, computer scientists, physicists and diverse groups of physicians are synergistic and create great opportunities for discovery relevant to better cancer care.
|